Clinical Trial Update: IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of IPH4102 (lacutamab) alone or in combination with chemotherapy is evaluating advanced T-cell lymphomas, including cutaneous T-cell ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• IPH4102 (lacutamab) (lacutamab)

Snippet

Sponsor: Innate Pharma | Conditions: Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous | Phase 2 | Status: ACTIVE_NOT_RECRUITING